Echinocandin Antifungal [EPC]

8210 reported adverse events

Drugs of this class: ANIDULAFUNGIN MICAFUNGIN MICAFUNGIN SODIUM REZAFUNGIN

These side effects are most commonly reported by patients taking drugs of the Echinocandin Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 1486
1 OFF LABEL USE 902
2 PYREXIA 580
3 FEBRILE NEUTROPENIA 482
4 MULTIPLE ORGAN DYSFUNCTION SYNDROME 431
5 SEPSIS 427
6 PNEUMONIA 388
7 PRODUCT USE IN UNAPPROVED INDICATION 362
8 SEPTIC SHOCK 356
9 NEUTROPENIA 322
See all common reactions for Echinocandin Antifungal [EPC]

Drugs of the Echinocandin Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 11 0.8462
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 WEISSELLA INFECTION 7 0.6364
3 PRE-ENGRAFTMENT IMMUNE REACTION 44 0.5500
4 PULMONARY TRICHOSPORONOSIS 8 0.3478
5 PROTOTHECOSIS 26 0.2766
6 GEOTRICHUM INFECTION 51 0.2417
7 AORTOENTERIC FISTULA 13 0.2031
8 CORYNEBACTERIUM BACTERAEMIA 17 0.2000
9 GASTROINTESTINAL MUCORMYCOSIS 25 0.1497
See all enriched reactions for Echinocandin Antifungal [EPC]